Body mass index and biliary tract disease: A systematic review and meta-analysis of prospective studies

Preventive Medicine

Volumn 65, Issue , 2014, Pages 13-22

  Park, Myungsook ^a   Song, Da Young ^b   Je, Youjin ^c   Lee, Jung Eun ^a  

^a Sookmyung Women's University   (South Korea)

^b National Cancer Center   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Biliary tract diseases; Biliary tract neoplasms; Body mass index; Cholecystitis; Cholelithiasis; Gallbladder; Neoplasms; Obesity

Indexed keywords

BILE DUCT DISEASE; BILIARY TRACT CANCER; BILIARY TRACT DISEASE; BODY MASS; DISEASE ASSOCIATION; GALLBLADDER DISEASE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; VATER PAPILLA; BIBLIOGRAPHIC DATABASE; BILIARY TRACT DISEASES; BILIARY TRACT NEOPLASMS; COMORBIDITY; CONFIDENCE INTERVAL; FEMALE; INCIDENCE; MALE; OBESITY; SEX RATIO;

BILIARY TRACT DISEASES; BILIARY TRACT NEOPLASMS; BODY MASS INDEX; COMORBIDITY; CONFIDENCE INTERVALS; DATABASES, BIBLIOGRAPHIC; FEMALE; HUMANS; INCIDENCE; MALE; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 84899830273     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2014.03.027     Document Type: Review

References (86)

1. Acalovschi M.V., Blendea D., Pascu M., Georoceanu A., Badea R.I., Prelipceanu M. Risk of asymptomatic and symptomatic gallstones in moderately obese women: a longitudinal follow-up study. Am. J. Gastroenterol. 1997, 92(1):127-131.
2. Ahrens W., Timmer A., Vyberg M., et al. Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study. Eur. J. Gastroenterol. Hepatol. 2007, 19(8):623-630.
3. Alvi A.R., Siddiqui N.A., Zafar H. Risk factors of gallbladder cancer in Karachi-a case-control study. World J. Surg. Oncol. 2011, 9:164.
4. Banim P.J., Luben R.N., Bulluck H., et al. The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk). Eur. J. Gastroenterol. Hepatol. 2011, 23(8):733-740.
5. Bennion L.J., Ginsberg R.L., Gernick M.B., Bennett P.H. Effects of oral contraceptives on the gallbladder bile of normal women. N. Engl. J. Med. 1976, 294(4):189-192.
6. Bergstrom A., Pisani P., Tenet V., Wolk A., Adami H.O. Overweight as an avoidable cause of cancer in Europe. Int. J. Cancer 2001, 91(3):421-430.
7. Boland L.L., Folsom A.R., Rosamond W.D., Atherosclerosis Risk in Communities Study (ARIC) Investigators Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease. A prospective study. Ann. Epidemiol. 2002, 12(2):131-140.
8. Braverman D.Z., Johnson M.L., Kern F. Effects of pregnancy and contraceptive steroids on gallbladder function. N. Engl. J. Med. 1980, 302(7):362-364.
9. Calle E.E., Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 2004, 4(8):579-591.
10. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003, 348(17):1625-1638.
11. Carriaga M.T., Henson D.E. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995, 75(1 Suppl.):171-190.
12. Chan J.M., Rimm E.B., Colditz G.A., Stampfer M.J., Willett W.C. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994, 17(9):961-969.
13. Chow W.H., McLaughlin J.K., Menck H.R., Mack T.M. Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA). Cancer Causes Control 1994, 5(3):267-272.
14. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7(3):177-188.
15. Dittrick G.W., Thompson J.S., Campos D., Bremers D., Sudan D. Gallbladder pathology in morbid obesity. Obes. Surg. 2005, 15(2):238-242.
16. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
17. Engeland A., Tretli S., Austad G., Bjorge T. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control 2005, 16(8):987-996.
18. Everhart J.E. Contributions of obesity and weight loss to gallstone disease. Ann. Intern. Med. 1993, 119(10):1029-1035.
19. Everhart J.E., Ruhl C.E. Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas. Gastroenterology 2009, 136(4):1134-1144.
20. Field A.E., Coakley E.H., Must A., et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch. Intern. Med. 2001, 161(13):1581-1586.
21. Gatta G., van der Zwan J.M., Casali P.G., et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur. J. Cancer 2011, 47(17):2493-2511.
22. González-Pérez A., García Rodríguez L.A. Gallbladder disease in the general population: association with cardiovascular morbidity and therapy. Pharmacoepidemiol. Drug Saf. 2007, 16(5):524-531.
23. Grainge M.J., West J., Solaymani-Dodaran M., Aithal G.P., Card T.R. The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br. J. Cancer 2009, 100(1):178-180.
24. Greenland S., Longnecker M.P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am. J. Epidemiol. 1992, 135(11):1301-1309.
25. Grodstein F., Colditz G.A., Hunter D.J., Manson J.E., Willett W.C., Stampfer M.J. A prospective study of symptomatic gallstones in women: relation with oral contraceptives and other risk factors. Obstet. Gynecol. 1994, 84(2):207-214.
26. Grodstein F., Colditz G.A., Stampfer M.J. Postmenopausal hormone use and cholecystectomy in a large prospective study. Obstet. Gynecol. 1994, 83(1):5-11.
27. Guh D.P., Zhang W., Bansback N., Amarsi Z., Birmingham C.L., Anis A.H. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009, 9:88.
28. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
29. Hsing A.W., Sakoda L.C., Rashid A., et al. Body size and the risk of biliary tract cancer: a population-based study in China. Br. J. Cancer 2008, 99(5):811-815.
30. Hung S.C., Liao K.F., Lai S.W., Li C.I., Chen W.C. Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study. BMC Gastroenterol. 2011, 11:111.
31. Ishiguro S., Inoue M., Kurahashi N., Iwasaki M., Sasazuki S., Tsugane S. Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification. Cancer Causes Control 2008, 19(1):33-41.
32. Jee S.H., Yun J.E., Park E.J., et al. Body mass index and cancer risk in Korean men and women. Int. J. Cancer 2008, 123(8):1892-1896.
33. Jeong S.U., Lee S.K. Obesity and gallbladder diseases. Korean J. Gastroenterol. 2012, 59(1):27-34.
34. Jung K.W., Won Y.J., Kong H.J., Oh C.M., Seo H.G., Lee J.S. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res. Treat. 2013, 45(1):1-14.
35. Kato I., Nomura A., Stemmermann G.N., Chyou P.H. Prospective study of clinical gallbladder disease and its association with obesity, physical activity, and other factors. Dig. Dis. Sci. 1992, 37(5):784-790.
36. Katsika D., Tuvblad C., Einarsson C., Lichtenstein P., Marschall H.U. Body mass index, alcohol, tobacco and symptomatic gallstone disease: a Swedish twin study. J. Intern. Med. 2007, 262(5):581-587.
37. Kivipelto M., Ngandu T., Fratiglioni L., et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch. Neurol. 2005, 62(10):1556-1560.
38. Ko C.W., Beresford S.A., Alderman B., et al. Apolipoprotein E genotype and the risk of gallbladder disease in pregnancy. Hepatology 2000, 31(1):18-23.
39. Ko C.W., Beresford S.A., Schulte S.J., Lee S.P. Insulin resistance and incident gallbladder disease in pregnancy. Clin. Gastroenterol. Hepatol. 2008, 6(1):76-81.
40. Ko C.W., Beresford S.A., Schulte S.J., Matsumoto A.M., Lee S.P. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology 2005, 41(2):359-365.
41. Kortt M.A., Langley P.C., Cox E.R. A review of cost-of-illness studies on obesity. Clin. Ther. 1998, 20(4):772-779.
42. Kuriyama S., Tsubono Y., Hozawa A., et al. Obesity and risk of cancer in Japan. Int. J. Cancer 2005, 113(1):148-157.
43. Larsson S.C., Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br. J. Cancer 2007, 96(9):1457-1461.
44. Layde P.M., Vessey M.P., Yeates D. Risk factors for gall-bladder disease: a cohort study of young women attending family planning clinics. J. Epidemiol. Community Health 1982, 36(4):274-278.
45. Lazcano-Ponce E.C., Miquel J.F., Munoz N., et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J. Clin. 2001, 51(6):349-364.
46. Liu B., Balkwill A., Spencer E., Beral V., Million Women Study C. Relationship between body mass index and length of hospital stay for gallbladder disease. J. Public Health (Oxf.) 2008, 30(2):161-166.
47. Liu B., Beral V., Balkwill A., Green J., Sweetland S., Reeves G. Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study. BMJ 2008, 337:a386.
48. Máchová L., Cízek L., Horáková D., et al. Association between obesity and cancer incidence in the population of the District Sumperk, Czech Republic. Onkologie 2007, 541(11):538-542.
49. Maclure K.M., Hayes K.C., Colditz G.A., Stampfer M.J., Speizer F.E., Willett W.C. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N. Engl. J. Med. 1989, 321(9):563-569.
50. Marzio L., Capone F., Neri M., Mezzetti A., De Angelis C., Cuccurullo F. Gallbladder kinetics in obese patients. Effect of a regular meal and low-calorie meal. Dig. Dis. Sci. 1988, 33(1):4-9.
51. Misciagna G., Centonze S., Leoci C., et al. Diet, physical activity, and gallstones-a population-based, case-control study in southern Italy. Am. J. Clin. Nutr. 1999, 69(1):120-126.
52. Misciagna G., Guerra V., Di Leo A., Correale M., Trevisan M. Insulin and gall stones: a population case control study in southern Italy. Gut 2000, 47(1):144-147.
53. Misciagna G., Leoci C., Guerra V., et al. Epidemiology of cholelithiasis in southern Italy. Part II: risk factors. Eur. J. Gastroenterol. Hepatol. 1996, 8(6):585-593.
54. Nakadaira H., Lang I., Szentirmay Z., Hitre E., Kaster M., Yamamoto M. A case-control study of gallbladder cancer in Hungary. Asian Pac. J. Cancer Prev. 2009, 10(5):833-836.
55. Ogden C.L., Yanovski S.Z., Carroll M.D., Flegal K.M. The epidemiology of obesity. Gastroenterology 2007, 132(6):2087-2102.
56. Oh S.W., Yoon Y.S., Shin S.A. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J. Clin. Oncol. 2005, 23(21):4742-4754.
57. Orsini N., Li R., Wolk A., Khudyakov P., Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am. J. Epidemiol. 2012, 175(1):66-73.
58. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113(6):898-918.
59. Randi G., Franceschi S., La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int. J. Cancer 2006, 118(7):1591-1602.
60. Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371(9612):569-578.
61. Robsahm T.E., Tretli S. Height, weight and gastrointestinal cancer: a follow-up study in Norway. Eur. J. Cancer Prev. 1999, 8(2):105-113.
62. Sahi T., Paffenbarger R.S., Hsieh C.C., Lee I.M. Body mass index, cigarette smoking, and other characteristics as predictors of self-reported, physician-diagnosed gallbladder disease in male college alumni. Am. J. Epidemiol. 1998, 147(7):644-651.
63. Samanic C., Chow W.H., Gridley G., Jarvholm B., Fraumeni J.F. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006, 17(7):901-909.
64. Schlesinger S., Aleksandrova K., Pischon T., et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int. J. Cancer 2013, 132(3):645-657.
65. Serra I., Yamamoto M., Calvo A., et al. Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int. J. Cancer 2002, 102(4):407-411.
66. Shaffer E.A. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract. Res. Clin. Gastroenterol. 2006, 20(6):981-996.
67. Sichieri R., Everhart J.E., Roth H. A prospective study of hospitalization with gallstone disease among women: role of dietary factors, fasting period, and dieting. Am. J. Public Health 1991, 81(7):880-884.
68. Song Y.M., Sung J., Ha M. Obesity and risk of cancer in postmenopausal Korean women. J. Clin. Oncol. 2008, 26(20):3395-3402.
69. Stampfer M.J., Maclure K.M., Colditz G.A., Manson J.E., Willett W.C. Risk of symptomatic gallstones in women with severe obesity. Am. J. Clin. Nutr. 1992, 55(3):652-658.
70. Strom B.L., Soloway R.D., Rios-Dalenz J.L., et al. Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer 1995, 76(10):1747-1756.
71. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012.
72. Syngal S., Coakley E.H., Willett W.C., Byers T., Williamson D.F., Colditz G.A. Long-term weight patterns and risk for cholecystectomy in women. Ann. Intern. Med. 1999, 130(6):471-477.
73. Tsai C.J., Leitzmann M.F., Willett W.C., Giovannucci E.L. Prospective study of abdominal adiposity and gallstone disease in US men. Am. J. Clin. Nutr. 2004, 80(1):38-44.
74. Tsai C.J., Leitzmann M.F., Willett W.C., Giovannucci E.L. Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men. Gut 2005, 54(6):823-828.
75. Tsai C.J., Leitzmann M.F., Willett W.C., Giovannucci E.L. Glycemic load, glycemic index, and carbohydrate intake in relation to risk of cholecystectomy in women. Gastroenterology 2005, 129(1):105-112.
76. van Kruijsdijk R.C., van der Wall E., Visseren F.L. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol. Biomarkers Prev. 2009, 18(10):2569-2578.
77. Venneman N.G., van Erpecum K.J. Pathogenesis of gallstones. Gastroenterol. Clin. N. Am. 2010, 39(2):171-183. vii.
78. Wang F., Wang B., Qiao L. Association between obesity and gallbladder cancer. Front. Biosci. (Landmark Ed.) 2012, 17:2550-2558.
79. Wells G.A., Shea B., O'Connell D., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis 2011, Dept of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Canada, (Available at http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 9 January 2013)).
80. WHO Obesity: preventing and managing the global epidemic 2000.
81. WHO International Statistical Classification of Diseases and Related Health Problems 10th Revision 2010.
82. Williams P.T. Independent effects of cardiorespiratory fitness, vigorous physical activity, and body mass index on clinical gallbladder disease risk. Am. J. Gastroenterol. 2008, 103(9):2239-2247.
83. Wistuba I.I., Gazdar A.F. Gallbladder cancer: lessons from a rare tumour. Nat. Rev. Cancer 2004, 4(9):695-706.
84. Wolf A.M., Colditz G.A. Current estimates of the economic cost of obesity in the United States. Obes. Res. 1998, 6(2):97-106.
85. Yoo E.H., Lee S.Y. The prevalence and risk factors for gallstone disease. Clin. Chem. Lab. Med. 2009, 47(7):795-807.
86. Zatonski W.A., Lowenfels A.B., Boyle P., et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J. Natl. Cancer Inst. 1997, 89(15):1132-1138.